Symbols / GDRX $2.24 +0.68%
GDRX Chart
About
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 765.65M |
| Enterprise Value | 1.04B | Income | 30.44M | Sales | 796.85M |
| Book/sh | 1.81 | Cash/sh | 0.76 | Dividend Yield | — |
| Payout | 0.00% | Employees | 697 | IPO | — |
| P/E | 24.83 | Forward P/E | 6.02 | PEG | — |
| P/S | 0.96 | P/B | 1.24 | P/C | — |
| EV/EBITDA | 8.52 | EV/Sales | 1.31 | Quick Ratio | 2.10 |
| Current Ratio | 2.61 | Debt/Eq | 88.08 | LT Debt/Eq | — |
| EPS (ttm) | 0.09 | EPS next Y | 0.37 | EPS Growth | -9.70% |
| Revenue Growth | -1.90% | Earnings | 2026-05-06 | ROA | 4.75% |
| ROE | 4.54% | ROIC | — | Gross Margin | 92.77% |
| Oper. Margin | 18.98% | Profit Margin | 3.82% | Shs Outstand | 108.61M |
| Shs Float | 95.69M | Short Float | 11.23% | Short Ratio | 2.70 |
| Short Interest | — | 52W High | 5.81 | 52W Low | 1.77 |
| Beta | 1.56 | Avg Volume | 3.22M | Volume | 709.36K |
| Target Price | $2.82 | Recom | Hold | Prev Close | $2.22 |
| Price | $2.23 | Change | 0.68% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$2.82
Mean price target
2. Current target
$2.23
Latest analyst target
3. DCF / Fair value
$13.58
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.23
Low
$1.90
High
$3.50
Mean
$2.82
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-04 | main | Wells Fargo | Overweight → Overweight | $4 |
| 2026-03-03 | main | Citigroup | Buy → Buy | $4 |
| 2026-03-02 | main | Goldman Sachs | Neutral → Neutral | $3 |
| 2026-02-27 | main | Mizuho | Neutral → Neutral | $3 |
| 2026-02-27 | down | JP Morgan | Overweight → Neutral | — |
| 2026-01-22 | down | Jefferies | Buy → Hold | $3 |
| 2026-01-09 | main | Citigroup | Buy → Buy | $5 |
| 2025-12-18 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $4 |
| 2025-12-09 | init | Barclays | — → Underweight | $3 |
| 2025-11-11 | main | JP Morgan | Overweight → Overweight | $5 |
| 2025-11-10 | main | TD Cowen | Buy → Buy | $6 |
| 2025-11-06 | main | UBS | Neutral → Neutral | $4 |
| 2025-11-06 | main | Mizuho | Neutral → Neutral | $4 |
| 2025-08-11 | main | UBS | Neutral → Neutral | $4 |
| 2025-05-13 | main | UBS | Neutral → Neutral | $5 |
| 2025-05-09 | main | Goldman Sachs | Neutral → Neutral | $5 |
| 2025-04-29 | main | Wells Fargo | Overweight → Overweight | $7 |
| 2025-04-10 | main | Truist Securities | Hold → Hold | $6 |
| 2025-02-28 | main | Wells Fargo | Overweight → Overweight | $8 |
| 2025-01-10 | main | Citigroup | Buy → Buy | $6 |
- $GDRX stock is down 8% today. Here's what we see in our data. - Quiver Quantitative Wed, 11 Mar 2026 19
- Lipitor and Viagra discounts: GoodRx deal cuts brand drugs to $0–$4 - Stock Titan Wed, 11 Mar 2026 13
- GoodRx’s (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8% - Yahoo Finance Wed, 25 Feb 2026 08
- GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st Mon, 19 Jan 2026 08
- 2 Small-Cap Stocks with Competitive Advantages and 1 That Underwhelm - StockStory Fri, 13 Mar 2026 09
- Wells Fargo & Company Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat Wed, 04 Mar 2026 08
- Why GoodRx (GDRX) Stock Is Trading Lower Today - Yahoo Finance ue, 09 Dec 2025 08
- GoodRx Holdings Inc. (GDRX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative hu, 26 Feb 2026 08
- Obesity drug Zepbound now offered to workers at $449 through GoodRx - Stock Titan Fri, 06 Mar 2026 08
- A Look at GoodRx (GDRX) Valuation Following a 27% One-Month Share Price Decline - Yahoo Finance Sun, 09 Nov 2025 08
- GoodRx (GDRX) CAO converts RSUs to stock and withholds shares for taxes - Stock Titan Mon, 09 Mar 2026 21
- $GDRX stock is down 11% today. Here's what we see in our data. - Quiver Quantitative hu, 02 Oct 2025 07
- Why GoodRx (GDRX) Stock Is Trading Up Today - Yahoo Finance Mon, 18 Aug 2025 07
- Employers get new way to cut Wegovy and GLP-1 costs with GoodRx - Stock Titan ue, 24 Feb 2026 08
- Why GoodRx (GDRX) Shares Are Sliding Today - Yahoo Finance Fri, 05 Sep 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 192185 | 90327.0 | — | Conversion of Exercise of derivative security at price 0.47 per share. | REY-GIRAUD AGNES | Director | — | 2026-03-12 00:00:00 | D |
| 1 | 75219 | — | — | Stock Gift at price 0.00 per share. | REY-GIRAUD AGNES | Director | — | 2026-03-12 00:00:00 | I |
| 2 | 12434 | nan | — | — | NABIEY ROMIN | Officer | — | 2026-03-06 00:00:00 | D |
| 3 | 179120 | nan | — | — | MCGINNIS CHRISTOPHER ALAN | Officer | — | 2026-02-13 00:00:00 | D |
| 4 | 4804 | nan | — | — | NABIEY ROMIN | Officer | — | 2026-02-13 00:00:00 | D |
| 5 | 12663 | nan | — | — | NABIEY ROMIN | Officer | — | 2026-02-06 00:00:00 | D |
| 6 | 31394 | nan | — | — | WAGNER SCOTT W. | Director | — | 2026-01-21 00:00:00 | D |
| 7 | 665302 | nan | — | — | BARNES WENDY LYNN | Officer and Director | — | 2026-01-15 00:00:00 | D |
| 8 | 18251 | — | — | Stock Award(Grant) at price 0.00 per share. | BRUEHLMAN RONALD E | Director | — | 2025-12-31 00:00:00 | D |
| 9 | 10950 | — | — | Stock Award(Grant) at price 0.00 per share. | HIRSCH DOUGLAS JOSEPH | Director | — | 2025-12-31 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | -436.17K | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.21 |
| NormalizedEBITDA | 184.36M | 156.00M | 108.82M | 65.19M |
| TotalUnusualItems | 0.00 | -2.08M | 0.00 | 0.00 |
| TotalUnusualItemsExcludingGoodwill | 0.00 | -2.08M | 0.00 | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | 30.44M | 16.39M | -8.87M | -32.83M |
| ReconciledDepreciation | 85.22M | 69.54M | 107.67M | 54.18M |
| ReconciledCostOfRevenue | 57.60M | 48.22M | 66.92M | 65.08M |
| EBITDA | 184.36M | 153.92M | 108.82M | 65.19M |
| EBIT | 99.14M | 84.38M | 1.16M | 11.01M |
| NetInterestIncome | -31.67M | -29.65M | -24.56M | -24.97M |
| InterestExpense | 42.60M | 52.92M | 56.73M | 34.24M |
| InterestIncome | 10.93M | 23.27M | 32.17M | 9.27M |
| NormalizedIncome | 30.44M | 18.03M | -8.87M | -32.83M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 30.44M | 16.39M | -8.87M | -32.83M |
| TotalExpenses | 709.36M | 726.48M | 777.27M | 764.82M |
| TotalOperatingIncomeAsReported | 87.49M | 65.85M | -27.01M | 1.74M |
| DilutedAverageShares | 356.97M | 392.17M | 410.31M | 412.86M |
| BasicAverageShares | 356.33M | 385.74M | 410.31M | 412.86M |
| DilutedEPS | 0.09 | 0.04 | -0.02 | -0.08 |
| BasicEPS | 0.09 | 0.04 | -0.02 | -0.08 |
| DilutedNIAvailtoComStockholders | 30.44M | 16.39M | -8.87M | -32.83M |
| AverageDilutionEarnings | 0.00 | |||
| NetIncomeCommonStockholders | 30.44M | 16.39M | -8.87M | -32.83M |
| OtherunderPreferredStockDividend | 0.00 | 0.00 | ||
| NetIncome | 30.44M | 16.39M | -8.87M | -32.83M |
| NetIncomeIncludingNoncontrollingInterests | 30.44M | 16.39M | -8.87M | -32.83M |
| NetIncomeContinuousOperations | 30.44M | 16.39M | -8.87M | -32.83M |
| TaxProvision | 26.10M | 15.07M | -46.70M | 9.60M |
| PretaxIncome | 56.54M | 31.46M | -55.57M | -23.23M |
| OtherIncomeExpense | 718.00K | -4.74M | -4.01M | |
| OtherNonOperatingIncomeExpenses | 718.00K | -2.66M | -4.01M | |
| SpecialIncomeCharges | 0.00 | -2.08M | 0.00 | 0.00 |
| OtherSpecialCharges | 2.08M | |||
| NetNonOperatingInterestIncomeExpense | -31.67M | -29.65M | -24.56M | -24.97M |
| InterestExpenseNonOperating | 42.60M | 52.92M | 56.73M | 34.24M |
| InterestIncomeNonOperating | 10.93M | 23.27M | 32.17M | 9.27M |
| OperatingIncome | 87.49M | 65.85M | -27.01M | 1.74M |
| OperatingExpense | 651.76M | 678.26M | 710.35M | 699.74M |
| DepreciationAmortizationDepletionIncomeStatement | 85.22M | 69.54M | 107.67M | 54.18M |
| DepreciationAndAmortizationInIncomeStatement | 85.22M | 69.54M | 107.67M | 54.18M |
| ResearchAndDevelopment | 121.03M | 123.75M | 135.84M | 143.14M |
| SellingGeneralAndAdministration | 445.52M | 484.98M | 466.84M | 502.42M |
| SellingAndMarketingExpense | 331.56M | 367.11M | 341.33M | 357.63M |
| GeneralAndAdministrativeExpense | 113.96M | 117.86M | 125.52M | 144.79M |
| OtherGandA | 113.96M | 117.86M | 125.52M | 144.79M |
| GrossProfit | 739.26M | 744.11M | 683.34M | 701.48M |
| CostOfRevenue | 57.60M | 48.22M | 66.92M | 65.08M |
| TotalRevenue | 796.85M | 792.32M | 750.26M | 766.55M |
| OperatingRevenue | 779.17M | 771.32M | 730.21M | 746.13M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 341.05M | 382.81M | 394.09M | 397.02M |
| ShareIssued | 341.05M | 382.81M | 394.09M | 397.02M |
| NetDebt | 226.44M | 43.37M | ||
| TotalDebt | 542.81M | 543.39M | 711.07M | 717.02M |
| TangibleBookValue | -17.41M | 137.01M | 194.85M | 212.77M |
| InvestedCapital | 1.10B | 1.22B | 1.42B | 1.47B |
| WorkingCapital | 397.10M | 535.35M | 750.23M | 843.37M |
| NetTangibleAssets | -17.41M | 137.01M | 194.85M | 212.77M |
| CapitalLeaseObligations | 54.54M | 51.68M | 54.58M | 58.20M |
| CommonStockEquity | 616.26M | 724.66M | 761.96M | 814.83M |
| TotalCapitalization | 1.10B | 1.21B | 1.41B | 1.47B |
| TotalEquityGrossMinorityInterest | 616.26M | 724.66M | 761.96M | 814.83M |
| StockholdersEquity | 616.26M | 724.66M | 761.96M | 814.83M |
| RetainedEarnings | -1.41B | -1.44B | -1.46B | -1.45B |
| AdditionalPaidInCapital | 2.03B | 2.17B | 2.22B | 2.26B |
| CapitalStock | 34.00K | 38.00K | 40.00K | 40.00K |
| CommonStock | 34.00K | 38.00K | 40.00K | 40.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 787.80M | 663.41M | 826.84M | 789.80M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 541.79M | 539.51M | 704.28M | 713.48M |
| OtherNonCurrentLiabilities | 8.74M | 6.75M | 8.18M | 7.56M |
| NonCurrentDeferredLiabilities | 244.00K | |||
| NonCurrentDeferredTaxesLiabilities | 244.00K | |||
| LongTermDebtAndCapitalLeaseObligation | 533.05M | 532.75M | 696.11M | 705.93M |
| LongTermCapitalLeaseObligation | 49.79M | 46.04M | 48.40M | 54.13M |
| LongTermDebt | 483.26M | 486.71M | 647.70M | 651.80M |
| CurrentLiabilities | 246.00M | 123.90M | 122.56M | 76.32M |
| OtherCurrentLiabilities | 130.14M | 15.80M | ||
| CurrentDeferredLiabilities | 6.71M | 6.04M | 7.11M | 7.88M |
| CurrentDeferredRevenue | 6.71M | 6.04M | 7.11M | 7.88M |
| CurrentDebtAndCapitalLeaseObligation | 9.75M | 10.64M | 14.96M | 11.10M |
| CurrentCapitalLeaseObligation | 4.75M | 5.64M | 6.18M | 4.07M |
| CurrentDebt | 5.00M | 5.00M | 8.79M | 7.03M |
| OtherCurrentBorrowings | 5.00M | 5.00M | 8.79M | 7.03M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 30.40M | 20.64M | 24.03M | |
| PayablesAndAccruedExpenses | 99.41M | 91.43M | 100.49M | 57.34M |
| CurrentAccruedExpenses | 80.00M | 75.84M | 64.22M | 39.64M |
| Payables | 19.41M | 15.59M | 36.27M | 17.70M |
| TotalTaxPayable | 0.00 | 1.46M | 0.00 | |
| IncomeTaxPayable | 0.00 | 1.46M | 0.00 | |
| AccountsPayable | 19.41M | 14.14M | 36.27M | 17.70M |
| TotalAssets | 1.40B | 1.39B | 1.59B | 1.60B |
| TotalNonCurrentAssets | 760.96M | 728.81M | 716.01M | 684.95M |
| OtherNonCurrentAssets | 29.09M | 23.52M | 37.77M | 27.16M |
| NonCurrentDeferredAssets | 57.11M | 77.18M | 65.27M | 0.00 |
| NonCurrentDeferredTaxesAssets | 57.11M | 77.18M | 65.27M | 0.00 |
| GoodwillAndOtherIntangibleAssets | 633.67M | 587.65M | 567.11M | 602.05M |
| OtherIntangibleAssets | 203.34M | 176.88M | 156.34M | 189.94M |
| Goodwill | 430.33M | 410.77M | 410.77M | 412.12M |
| NetPPE | 41.08M | 40.46M | 45.86M | 55.73M |
| AccumulatedDepreciation | -22.29M | -18.23M | -13.79M | -9.77M |
| GrossPPE | 63.37M | 58.69M | 59.65M | 65.50M |
| Leases | 16.11M | 16.17M | 16.00M | 16.09M |
| ConstructionInProgress | 3.32M | 308.00K | 169.00K | 0.00 |
| OtherProperties | 28.81M | 27.79M | 29.93M | 35.91M |
| MachineryFurnitureEquipment | 15.13M | 14.42M | 13.55M | 13.49M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 643.10M | 659.25M | 872.79M | 919.69M |
| OtherCurrentAssets | 126.41M | 50.08M | 40.45M | 35.10M |
| RestrictedCash | 0.00 | |||
| PrepaidAssets | 0.00 | 5.75M | 0.00 | |
| Receivables | 254.87M | 160.83M | 160.04M | 121.67M |
| OtherReceivables | 11.90M | 14.90M | 12.90M | |
| TaxesReceivable | 7.22M | 0.00 | 3.54M | 4.52M |
| AccountsReceivable | 235.75M | 145.93M | 143.61M | 117.14M |
| CashCashEquivalentsAndShortTermInvestments | 261.82M | 448.35M | 672.30M | 757.16M |
| CashAndCashEquivalents | 261.82M | 448.35M | 672.30M | 757.16M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 93.88M | 113.55M | 82.53M | 91.57M |
| RepurchaseOfCapitalStock | -216.37M | -158.84M | -103.97M | -101.72M |
| RepaymentOfDebt | -5.00M | -639.04M | -5.27M | -7.03M |
| IssuanceOfDebt | 0.00 | 472.03M | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 0.00 | 0.00 | ||
| CapitalExpenditure | -74.02M | -70.35M | -55.77M | -55.21M |
| InterestPaidSupplementalData | 40.84M | 55.10M | 48.80M | 30.70M |
| IncomeTaxPaidSupplementalData | 13.13M | 23.62M | 17.24M | 4.36M |
| EndCashPosition | 261.82M | 448.35M | 672.30M | 757.16M |
| BeginningCashPosition | 448.35M | 672.30M | 757.16M | 941.11M |
| ChangesInCash | -186.53M | -223.95M | -84.87M | -183.94M |
| FinancingCashFlow | -234.47M | -337.50M | -167.40M | -120.23M |
| CashFlowFromContinuingFinancingActivities | -234.47M | -337.50M | -167.40M | -120.23M |
| NetOtherFinancingCharges | -14.47M | -32.46M | -65.48M | -20.64M |
| ProceedsFromStockOptionExercised | 1.37M | 20.81M | 7.33M | 9.16M |
| NetCommonStockIssuance | -216.37M | -158.84M | -103.97M | -101.72M |
| CommonStockPayments | -216.37M | -158.84M | -103.97M | -101.72M |
| CommonStockIssuance | 0.00 | 0.00 | ||
| NetIssuancePaymentsOfDebt | -5.00M | -167.00M | -5.27M | -7.03M |
| NetLongTermDebtIssuance | -5.00M | -167.00M | -5.27M | -7.03M |
| LongTermDebtPayments | -5.00M | -639.04M | -5.27M | -7.03M |
| LongTermDebtIssuance | 0.00 | 472.03M | 0.00 | 0.00 |
| InvestingCashFlow | -119.96M | -70.35M | -55.77M | -210.50M |
| CashFlowFromContinuingInvestingActivities | -119.96M | -70.35M | -55.77M | -210.50M |
| NetOtherInvestingChanges | -2.50M | |||
| NetBusinessPurchaseAndSale | -43.44M | 0.00 | 0.00 | -155.28M |
| SaleOfBusiness | 0.00 | 0.00 | 16.58M | 0.00 |
| PurchaseOfBusiness | -43.44M | 0.00 | 0.00 | -171.86M |
| NetPPEPurchaseAndSale | -3.52M | -1.24M | -1.04M | -3.97M |
| PurchaseOfPPE | -3.52M | -1.24M | -1.04M | -3.97M |
| CapitalExpenditureReported | -70.50M | -69.11M | -54.72M | -51.25M |
| OperatingCashFlow | 167.90M | 183.89M | 138.29M | 146.78M |
| CashFlowFromContinuingOperatingActivities | 167.90M | 183.89M | 138.29M | 146.78M |
| ChangeInWorkingCapital | -56.44M | 2.09M | -21.94M | -20.29M |
| ChangeInOtherCurrentLiabilities | 110.06M | 4.00M | 3.41M | -1.88M |
| ChangeInOtherCurrentAssets | -75.39M | -7.46M | -15.48M | |
| ChangeInPayablesAndAccruedExpense | 5.29M | -5.91M | 33.29M | -6.14M |
| ChangeInAccruedExpense | 1.19M | 9.91M | 21.25M | -5.27M |
| ChangeInPayable | 4.10M | -15.82M | 12.03M | -874.00K |
| ChangeInAccountPayable | 4.10M | -15.82M | 12.03M | -874.00K |
| ChangeInPrepaidAssets | -8.39M | 13.79M | -16.68M | -13.64M |
| ChangeInReceivables | -88.02M | -2.33M | -26.47M | 1.38M |
| ChangesInAccountReceivables | -88.02M | -2.33M | -26.47M | 1.38M |
| OtherNonCashItems | 7.58M | 6.68M | 12.84M | 24.82M |
| StockBasedCompensation | 76.63M | 99.03M | 104.82M | 120.23M |
| DeferredTax | 20.07M | -11.91M | -65.56M | -497.00K |
| DeferredIncomeTax | 20.07M | -11.91M | -65.56M | -497.00K |
| DepreciationAmortizationDepletion | 85.22M | 69.54M | 107.67M | 54.18M |
| DepreciationAndAmortization | 85.22M | 69.54M | 107.67M | 54.18M |
| AmortizationCashFlow | 102.90M | |||
| AmortizationOfIntangibles | 102.90M | |||
| Depreciation | 4.80M | |||
| OperatingGainsLosses | 4.41M | 2.08M | 9.33M | 1.17M |
| EarningsLossesFromEquityInvestments | 4.01M | 0.00 | 0.00 | |
| GainLossOnSaleOfPPE | 4.41M | 0.00 | 9.33M | 0.00 |
| GainLossOnSaleOfBusiness | 0.00 | 0.00 | -11.40M | 0.00 |
| NetIncomeFromContinuingOperations | 30.44M | 16.39M | -8.87M | -32.83M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for GDRX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|